INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE);CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE;INSTITUT CLAUDIUS REGAUD;UNIVERSITÉ PAULS SABATIER TOULOUSE III
发明人:
Bruno Segui,Nathalie Andrieu-Abadie,Thierry Levade,Celine Colacios Viatge,Philippe Rochaix,Florie Bertrand,Herve Benoist,Julia Rochotte
申请号：
US15310158
公开号：
US10144772B2
申请日:
2015.05.12
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to a TNFα blocking agent for use in the treatment and prevention of melanoma in a subject in whom melanoma cells express MHCI and in whom stroma cells exhibit TNF expression.
